145 related articles for article (PubMed ID: 35809319)
1. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
[TBL] [Abstract][Full Text] [Related]
2. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
3. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
4. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
5. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
7. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Teng Y; Zhao X; Xi Y; Fu N
Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
[TBL] [Abstract][Full Text] [Related]
9. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
[TBL] [Abstract][Full Text] [Related]
10. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12.
Sun Y; Liu Y; Wang P; Chang L; Huang J
Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673
[TBL] [Abstract][Full Text] [Related]
11. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma.
Li Y; Gu J; Xu F; Zhu Q; Chen Y; Ge D; Lu C
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33003204
[TBL] [Abstract][Full Text] [Related]
13. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
[TBL] [Abstract][Full Text] [Related]
14. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
[TBL] [Abstract][Full Text] [Related]
15. YTHDF1 Promotes Cyclin B1 Translation through m
Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
[TBL] [Abstract][Full Text] [Related]
16. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
Nie G; Tang B; Lv M; Li D; Li T; Ou R; Xu Y; Wen J
Cell Biol Int; 2023 Aug; 47(8):1327-1343. PubMed ID: 37191290
[TBL] [Abstract][Full Text] [Related]
17. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
Meng Y; Zhang Q; Wang K; Zhang X; Yang R; Bi K; Chen W; Diao H
Cell Death Dis; 2021 Jul; 12(8):732. PubMed ID: 34301919
[TBL] [Abstract][Full Text] [Related]
18. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
Liu J; Zheng Z; Zhong J
J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]